CDK19 and prostate carcinoma: Furthermore, the oncogenic role of approximately 100 of the cancer-related genes in ETV4-fusion-positive prostate cancers were suggested, and consistently, as an example, a recent study reported that CDK19 is highly expressed in prostate cancer and increases aggressiveness and regulates the progression of prostate cancer [14].